CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $82.94 -9.27%
Financial Fact:
Income tax provision: 921M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income tax provision: 921M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.21, $0.08 better than the analyst estimate of $2.13. Revenue for the quarter came in at $88.92 billion versus the consensus estimate of $86.41 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.50-$8.70, versus the consensus of $8.59.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
- Datadog stock tumbles 19% despite earnings beat
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
